Do patients followed in anticoagulation clinics for antiphospholipid syndrome meet criteria for the disorder?

Thrombosis and Haemostasis

Volumn 94, Issue 3, 2005, Pages 548-554

  Dunn, Andrew S ^a   Kaboli, Peter ^b   Halfdanarson, Thorvardur ^c   Chan, Happy ^d   Hubert, Rod ^d   Rosen, Seth ^b   White, Richard H ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticardiolipin antibody; Anticoagulation; Antiphospholipid antibody syndrome; Diagnosis; Lupus anticoagulant

Indexed keywords

CARDIOLIPIN ANTIBODY; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PUBLISHING; REVIEW; SEROLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CROSS-SECTIONAL STUDIES; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; MASS SCREENING; MEDICAL RECORDS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; WARFARIN;

EID: 24944472305     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-11-0756     Document Type: Review

References (27)

1. Manoussakis MN, Tzioufas AG, Silis MP et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exper Immunol 1987; 69: 557-65.
2. Petri M: Epidemiology of the antiphospholipid antibody syndrome. J Autoimmunity 2000; 15: 145-51.
3. Thomas RH. Hypercoagulability syndromes. Arch Intern Med 2001; 161: 2433-9.
4. Stegnar M, Bozic B, Peternel P et al. Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis. Thromb Res 1991; 63: 433-43.
5. Simioni P, Prandoni P, Zanon E et al. Deep venous thrombosis and lupus anticoagulant. A case-control study. Thromb Haemost 1996; 76: 187-9.
6. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
7. Crowther MA, Ginsberg JS, Julian J et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003; 349: 1133-8.
8. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
9. Harris EN, Chan JK, Asherson RA et al. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-6.
10. Finazzi G. The Italian Registry of Antiphospholipid Antibodies. Haematologica 1997; 82: 101-5.
11. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119(1 Suppl): 1765-1935.
12. Lockshin MD. Antiphospholipid antibody. Babies, blood clots, biology. JAMA 1997; 277: 1549-51.
13. Long AA, Ginsberg JS, Brill-Edwards P, et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 1991; 66: 520-4.
14. Muir KW, Squire IB, Alwan W et al. Anticardiolipin antibodies in an unselected stroke population. Lancet 1994; 344: 452-6.
15. Mateo J, Oliver A, Borrell M et al. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - results of the Spanish Multicentric Study on Thrombophilia (EMET Study). Thromb Haemost 1997; 77: 444-51.
16. Cabiedes J, Cabral AR, Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
17. Cervera R, Font J, Lopez-Soto A, et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 1990; 49: 109-13.
18. Italian Registry of Antiphospholipid Antibodies. Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): first report from the Italian Registry. Haematologica 1993; 78: 313-8.
19. The Antiphospholipid Antibodies in Stroke Study Group (APASS). Clinical, radiological, and pathological aspects of cerebrovascular disease associated with antiphospholipid antibodies. Stroke 1993; 24(12 Suppl): I120-3.
20. Ginsberg JS, Wells PS, Brill-Edwards P et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-91.
21. Cabral AR, Cabiedes J, Alarcon-Segovia D. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol 1995; 22: 1894-8.
22. Finazzi G, Brancaccio V, Moia M et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 1996; 100: 530-6.
23. Jouhikainen T. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy. Blood Coagul Fibrinolysis 1990; 1: 627-32.
24. Lillicrap DP, Pinto M, Benford K et al. Heterogeneity of laboratory test results for antiphospholipid antibodies in patients treated with chlorpromazine and other phenothiazines. Am J Clin Pathol 1990; 93: 771-5.
25. Levy RA, Gharavi AE, Sammaritano LR et al. Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis. J Rheumatol 1990; 17: 1036-41.
26. Canoso RT, Zon LI, Groopman JE Anticardiolipin antibodies associated with HTLV-III infection. Br J Haematol 1987; 65: 495-8.
27. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-65.